McKenna Mark C.
Chairman, President & CEO at Prometheus Biosciences, Inc.; President, Salix at BHC
- Sold, on record
- $15.2M
- Dollars the filings state
- Form 4 sales
- 5
- Latest Mar 15, 2023
- Form 144 notices
- 0
- Proposed sales
- Companies
- 2
- Filed as an executive or holder
Companies
- Prometheus Biosciences, Inc.Chairman, President & CEO
- BHCBausch Health Companies Inc.President, Salix
Sales by reason
Form 4 sales per month, last 12 months.
Sales by company
- Prometheus Biosciences, Inc.125,000 shares
- BHC10,773 shares
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 4 sale BHCUnusualAug 19, 2019 2019
Sold 10,773 shares at $21.83 ($235k)
McKenna Mark C., President, Salix
Sold 34.2% of holdings ($688k position)20,756 shares leftFirst sale on recordFiling
- 2 Form 4 sale Prometheus Biosciences, Inc.UnusualJan 17, 2023 +1247 days
Sold 25,000 shares at $118.99 ($3M)
McKenna Mark C., Chairman, President & CEO
Sold 31.2% of holdings ($9.5M position)55,144 shares leftFirst sale on recordFiling
- 3 Form 4 sale Prometheus Biosciences, Inc.UnusualFeb 17, 2023 +31 days
Sold 63,680 shares at $120.82 ($7.7M)
McKenna Mark C., Chairman, President & CEO
Sold 53.6% of holdings ($14.4M position)55,144 shares leftFiling
- 4 Form 4 sale Prometheus Biosciences, Inc.Plan not statedMar 3, 2023 +14 days
Sold 11,320 shares at $125.14 ($1.4M)
McKenna Mark C., Chairman, President & CEO
Sold 17% of holdings ($8.3M position)55,144 shares leftFiling
- 5 Form 4 sale Prometheus Biosciences, Inc.UnusualMar 15, 2023 +12 days
Sold 25,000 shares at $116.14 ($2.9M)
McKenna Mark C., Chairman, President & CEO
Sold 31.2% of holdings ($9.3M position)55,144 shares left1x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (5)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Mar 15, 2023 | Mar 17, 2023 | Prometheus Biosciences, Inc. | Chairman, President & CEO | Form 4 sale | 25,000 | $2.9M | 31.2% | Unusual | SEC |
| Mar 3, 2023 | Mar 3, 2023 | Prometheus Biosciences, Inc. | Chairman, President & CEO | Form 4 sale | 11,320 | $1.4M | 17.0% | Plan not stated | SEC |
| Feb 17, 2023 | Feb 17, 2023 | Prometheus Biosciences, Inc. | Chairman, President & CEO | Form 4 sale | 63,680 | $7.7M | 53.6% | Unusual | SEC |
| Jan 17, 2023 | Jan 19, 2023 | Prometheus Biosciences, Inc. | Chairman, President & CEO | Form 4 sale | 25,000 | $3M | 31.2% | Unusual | SEC |
| Aug 19, 2019 | Aug 21, 2019 | BHC | President, Salix | Form 4 sale | 10,773 | $235k | 34.2% | Unusual | SEC |